Answers are grounded in this paper and cite their sources.
RA patients with longer disease duration do not respond as well to treatment compared with patients with early disease, and female sex, prior DMARD use, disease functional class, and disease activity also have effects on the likelihood of patient response to treatment. This has implications for trial interpretation and for the clinical expectations of RA patients.
No takes yet. Share an insight, caveat, or question.
Anderson et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: